Recently, it has been demonstrated that tandem repeats regions of MUC1 are able to activate NF-κB, a transcription factor implemented in pro-inflammatory responses, the induction of resistance to chemotherapy, tumor progression, invasion, and metastasis [83,107]. This evidence concerns the gene MUC1 and neoplasm.